Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Giorgio Patelli

Medical Oncologist

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Andrea Sartore-Bianchi

Full Professor of Oncology

Università degli Studi di Torino

ITALY

View details

Renata Grifantini

General Director and Chief Scientific Officer

ITALY

View details

Luigi Asmundo

Radiologist

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

ITALY

View details

Giovanni Crisafulli

Università degli Studi di Torino

ITALY

View details

Alberto Bardelli

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giorgio Patelli

Research Interests

Make your next move.

Explore related searches

Articles (20)

Adaptive plasticity in targeted therapy

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies

Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial

Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors

Clinical Actionability of Genes in Gastrointestinal Tumors

Detecting Cancer Early with Ultrasensitive Multimodal Liquid Biopsy

Clinical utility and future perspectives of liquid biopsy in colorectal cancer

Tumor “age” in early-onset colorectal cancer

Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review

Association between site of metastases and survival stratification of the IMDC classification in metastatic renal cell carcinoma (mRCC).

Immunocytokines in cancer treatment: A systematic review

Renal cell carcinoma in kidney transplant recipients receiving immunosuppression: A 55-year retrospective single-center study.

Early-onset cancers: Biological bases and clinical implications

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.

Clinicopathological characterisation of <i>MTAP</i> alterations in gastrointestinal cancers.

Total neoadjuvant treatment (TNT) with non-operative management (NOM) for proficient mismatch repair locally advanced rectal cancer (pMMR LARC): First results of NO-CUT trial

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer (Frontiers in Oncology, (2022), 12, (1030232), 10.3389/fonc.2022.1030232)

Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report

Collaborators (5)

Andrea Sartore-Bianchi

Renata Grifantini

Luigi Asmundo

Giovanni Crisafulli

Alberto Bardelli

Make your next move.